Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion

Microbes and Infection

Volumn 8, Issue 6, 2006, Pages 1579-1591

  Giles, David K ^a   Whittimore, Judy D ^a   LaRue, Richard W ^a   Raulston, Jane E ^a   Wyrick, Priscilla B ^a  

^a East Tennessee State University   (United States)

Author keywords

Antigen escape; Azithromycin; Chlamydia trachomatis; Inclusion membrane proteins (Inc); Vesicle formation

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL ANTIGEN; HEAT SHOCK PROTEIN 60; ISOPROTEIN; MEMBRANE PROTEIN;

ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; CELL INCLUSION; CELL SURFACE; CELL VACUOLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DRUG EXPOSURE; ELECTRON MICROSCOPY; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; NEUTROPHIL; POLARIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEROTYPE; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; AZITHROMYCIN; BACTERIAL PROTEINS; CELL LINE; CHAPERONIN 60; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOPLASMIC VESICLES; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; GOLGI APPARATUS; HUMANS; INCLUSION BODIES; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, IMMUNOELECTRON; MOLECULAR SEQUENCE DATA;

CHLAMYDIA TRACHOMATIS; CHLAMYDIAE;

EID: 33745142612     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.01.018     Document Type: Article

References (80)

1. Schachter J. What is the minimally effective treatment for Chlamydia trachomatis infection? The compliance paradox. Sex. Transm. Dis. 26 (1999) 279-280
2. Workowski K.A., and Berman S.M. CDC sexually transmitted diseases treatment guidelines. Clin. Infect. Dis. 35 (2002) S135-S137
3. Paul T.R., Knight S.T., Raulston J.E., and Wyrick P.B. Delivery of azithromycin to Chlamydia trachomatis-infected polarized human endometrial epithelial cells by polymorphonuclear leucocytes. J. Antimicrob. Chemother. 39 (1997) 623-630
4. Raulston J.E. Pharmacokinetics of azithromycin and erythromycin in human endometrial epithelial cells and in cells infected with Chlamydia trachomatis. J. Antimicrob. Chemother. 34 (1994) 765-776
5. Engel J.N. Azithromycin-induced block of elementary body formation in Chlamydia trachomatis. Antimicrob. Agents Chemother. 36 (1992) 2304-2309
6. Wyrick P.B., Davis C.H., Raulston J.E., Knight S.T., and Choong J. Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis. Clin. Infect. Dis. 19 (1994) 931-936
7. Wildfeuer A., Laufen H., Muller-Wening D., and Haferkamp O. Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes. Arzneimittelforschung 39 (1989) 755-758
8. Welsh L.E., Gaydos C.A., and Quinn T.C. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36 (1992) 291-294
9. Wyrick P.B., Davis C.H., Knight S.T., and Choong J. In-vitro activity of azithromycin on Chlamydia trachomatis infected, polarized human endometrial epithelial cells. J. Antimicrob. Chemother. 31 (1993) 139-150
10. Steingrimsson O., Olafsson J.H., Thorarinsson H., Ryan R.W., Johnson R.B., and Tilton R.C. Azithromycin in the treatment of sexually transmitted disease. J. Antimicrob. Chemother. 25 Suppl. A (1990) 109-114
11. Johnson R.B. The role of azalide antibiotics in the treatment of Chlamydia. Am. J. Obstet. Gynecol. 164 (1991) 1794-1796
12. Martin D.H., Mroczkowski T.F., Dalu Z.A., McCarty J., Jones R.B., Hopkins S.J., and Johnson R.B. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N. Engl. J. Med. 327 (1992) 921-925
13. Wyrick P.B., Knight S.T., Paul T.R., Rank R.G., and Barbier C.S. Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis. J. Infect. Dis. 179 (1999) 954-966
14. Byrne G.I., and Ojcius D.M. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat. Rev. Microbiol. 2 (2004) 802-808
15. Wyrick P., Choong J., Knight S., Goyeau D., Stuart E.S., and Macdonald A. Chlamydia trachomatis antigens on the surface of infected human endometrial epithelial cells. Immun. Infect. Dis. 4 (1994) 131-141
16. Zhong G., Fan P., Ji H., Dong F., and Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193 (2001) 935-942
17. Heuer D., Brinkmann V., Meyer T.F., and Szczepek A.J. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell. Microbiol. 5 (2003) 315-322
18. Patton D.L., Sweeney Y.T.C., and Stamm W.E. Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment. J. Infect. Dis. 192 (2005) 129-135
19. Morrison R.P., and Caldwell H.D. Immunity to murine chlamydial genital infection. Infect. Immun. 70 (2002) 2741-2751
20. Pal S., Peterson E., and de la Maza L. Vaccination with the Chlamydia trachomatis (CT) major outer membrane protein (MOMP) can induce protection against a genital challenge. In: Deak J. (Ed). Proceedings: Fifth Meeting of the European Society for Chlamydia Research (2004), Pauker Nyomdaipari Kft, Budapest, Hungary 394
21. Heine H., Muller-Loennies S., Brade L., Lindner B., and Brade H. Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur. J. Biochem. 270 (2003) 440-450
22. Morrison R.P., Belland R.J., Lyng K., and Caldwell H.D. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J. Exp. Med. 170 (1989) 1271-1283
23. Wagar E.A., Schachter J., Bavoil P., and Stephens R.S. Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J. Infect. Dis. 162 (1990) 922-927
24. Brunham R.C., and Peeling R.W. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect. Agents. Dis. 3 (1994) 218-233
25. Arno J.N., Yuan Y., Cleary R.E., and Morrison R.P. Serologic responses of infertile women to the 60-kd chlamydial heat shock protein (hsp60). Fertil. Steril. 64 (1995) 730-735
26. Claman P., Honey L., Peeling R.W., Jessamine P., and Toye B. The presence of serum antibody to the chlamydial heat shock protein (CHSP60) as a diagnostic test for tubal factor infertility. Fertil. Steril. 67 (1997) 501-504
27. Kinnunen A., Molander P., Morrison R., Lehtinen M., Karttunen R., Tiitinen A., Paavonen J., and Surcel H.M. Chlamydial heat shock protein 60-specific T cells in inflamed salpingeal tissue. Fertil. Steril. 77 (2002) 162-166
28. Lichtenwalner A.B., Patton D.L., Van Voorhis W.C., Sweeney Y.T., and Kuo C.C. Heat shock protein 60 is the major antigen which stimulates delayed-type hypersensitivity reaction in the macaque model of Chlamydia trachomatis salpingitis. Infect. Immun. 72 (2004) 1159-1161
29. Stephens R.S. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 11 (2003) 44-51
30. Debattista J., Timms P., and Allan J. Reduced levels of gamma-interferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections. Immunol. Lett. 81 (2002) 205-210
31. Stephens R.S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., Mitchell W., Olinger L., Tatusov R.L., Zhao Q., Koonin E.V., and Davis R.W. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282 (1998) 754-759
32. Gerard H.C., Whittum-Hudson J.A., Schumacher H.R., and Hudson A.P. Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb. Pathog. 36 (2004) 35-39
33. Tam J.E., Knight S.T., Davis C.H., and Wyrick P.B. Eukaryotic cells grown on microcarrier beads offer a cost-efficient way to propagate Chlamydia trachomatis. Biotechniques 13 (1992) 374-378
34. Wyrick P.B., Gerbig Jr. D.G., Knight S.T., and Raulston J.E. Accelerated development of genital Chlamydia trachomatis serovar E in McCoy cells grown on microcarrier beads. Microb. Pathog. 20 (1996) 31-40
35. Wyrick P.B., Davis C.H., Knight S.T., Choong J., Raulston J.E., and Schramm N. An in vitro human epithelial cell culture system for studying the pathogenesis of Chlamydia trachomatis. Sex. Transm. Dis. 20 (1993) 248-256
36. Dessus-Babus S., Knight S.T., and Wyrick P.B. Chlamydial infection of polarized HeLa cells induces PMN chemotaxis but the cytokine profile varies between disseminating and non-disseminating strains. Cell. Microbiol. 2 (2000) 317-327
37. Bannantine J.P., Rockey D.D., and Hackstadt T. Tandem genes of Chlamydia psittaci that encode proteins localized to the inclusion membrane. Mol. Microbiol. 28 (1998) 1017-1026
38. Bannantine J.P., Stamm W.E., Suchland R.J., and Rockey D.D. Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect. Immun. 66 (1998) 6017-6021
39. Hackstadt T., Scidmore-Carlson M.A., Shaw E.I., and Fischer E.R. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell. Microbiol. 1 (1999) 119-130
40. Scidmore-Carlson M.A., Shaw E.I., Dooley C.A., Fischer E.R., and Hackstadt T. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol. Microbiol. 33 (1999) 753-765
41. Bannantine J.P., Griffiths R.S., Viratyosin W., Brown W.J., and Rockey D.D. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell. Microbiol. 2 (2000) 35-47
42. Hackstadt T., Fischer E.R., Scidmore M.A., Rockey D.D., and Heinzen R.A. Origins and functions of the chlamydial inclusion. Trends Microbiol. 5 (1997) 288-293
43. Fields K.A., and Hackstadt T. The chlamydial inclusion: escape from the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 18 (2002) 221-245
44. Carabeo R.A., Mead D.J., and Hackstadt T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc. Natl. Acad. Sci. USA 100 (2003) 6771-6776
45. Raulston J.E., Paul T.R., Knight S.T., and Wyrick P.B. Localization of Chlamydia trachomatis heat shock proteins 60 and 70 during infection of a human endometrial epithelial cell line in vitro. Infect. Immun. 66 (1998) 2323-2329
46. Richmond S.J., and Stirling P. Localization of chlamydial group Antigen in McCoy cell monolayers infected with Chlamydia trachomatis or Chlamydia psittaci. Infect. Immun. 34 (1981) 561-570
47. Karimi S.T., Schloemer R.H., and Wilde III C.E. Accumulation of chlamydial lipopolysaccharide antigen in the plasma membranes of infected cells. Infect. Immun. 57 (1989) 1780-1785
48. Wilde C.E., Karimi S., and Haak R.A. Cell surface alterations during chlamydial infection. In: Leive L., and Bonventre P.F. (Eds). Microbiology-1986 (1986), ASM Press, Washington, DC, USA 96-98
49. Matsumoto A., and Manire G.P. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J. Bacteriol. 101 (1970) 278-285
50. Brown W.J., Skeiky Y.A., Probst P., and Rockey D.D. Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol. Infect. Immun. 70 (2002) 5860-5864
51. Dorward D.W., Garon C.F., and Judd R.C. Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae. J. Bacteriol. 171 (1989) 2499-2505
52. Beveridge T.J. Structures of gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181 (1999) 4725-4733
53. Kolling G.L., and Matthews K.R. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl. Environ. Microbiol. 65 (1999) 1843-1848
54. Kesty N.C., and Kuehn M.J. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J. Biol. Chem. 279 (2004) 2069-2076
55. Kesty N.C., Mason K.M., Reedy M., Miller S.E., and Kuehn M.J. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 23 (2004) 4538-4549
56. Delevoye C., Nilges M., Dautry-Varsat A., and Subtil A. Conservation of the biochemical properties of IncA from Chlamydia trachomatis and Chlamydia caviae: oligomerization of IncA mediates interaction between facing membranes. J. Biol. Chem. 279 (2004) 46896-46906
57. Suchland R.J., Rockey D.D., Bannantine J.P., and Stamm W.E. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect. Immun. 68 (2000) 360-367
58. Rzomp K.A., Scholtes L.D., Briggs B.J., Whittaker G.R., and Scidmore M.A. Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect. Immun. 71 (2003) 5855-5870
59. Igietseme J.U., Magee D.M., Williams D.M., and Rank R.G. Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect. Immun. 62 (1994) 5195-5197
60. Fling S.P., Sutherland R.A., Steele L.N., Hess B., D'Orazio S.E., Maisonneuve J., Lampe M.F., Probst P., and Starnbach M.N. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 98 (2001) 1160-1165
61. Starnbach M.N., Loomis W.P., Ovendale P., Regan D., Hess B., Alderson M.R., and Fling S.P. An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response. J. Immunol. 171 (2003) 4742-4749
62. Kovacsovics-Bankowski M., and Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267 (1995) 243-246
63. Houde M., Bertholet S., Gagnon E., Brunet S., Goyette G., Laplante A., Princiotta M.F., Thibault P., Sacks D., and Desjardins M. Phagosomes are competent organelles for antigen cross-presentation. Nature 425 (2003) 402-406
64. Gagnon E., Duclos S., Rondeau C., Chevet E., Cameron P.H., Steele-Mortimer O., Paiement J., Bergeron J.J., and Desjardins M. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110 (2002) 119-131
65. Brunet S., Thibault P., Gagnon E., Kearney P., Bergeron J.J., and Desjardins M. Organelle proteomics: looking at less to see more. Trends Cell Biol. 13 (2003) 629-638
66. Celli J., de Chastellier C., Franchini D.M., Pizarro-Cerda J., Moreno E., and Gorvel J.P. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198 (2003) 545-556
67. Wylie J.L., Hatch G.M., and McClarty G. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J. Bacteriol. 179 (1997) 7233-7242
68. Zhong G., Liu L., Fan T., Fan P., and Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in Chlamydia-infected cells. J. Exp. Med. 191 (2000) 1525-1534
69. Stenner-Liewen F., Liewen H., Zapata J.M., Pawlowski K., Godzik A., and Reed J.C. CADD, a Chlamydia protein that interacts with death receptors. J. Biol. Chem. 277 (2002) 9633-9636
70. Bavoil P.M., and Hsia R.C. Type III secretion in Chlamydia: a case of deja vu?. Mol. Microbiol. 28 (1998) 860-862
71. Fields K.A., and Hackstadt T. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol. Microbiol. 38 (2000) 1048-1060
72. Fields K.A., Mead D.J., Dooley C.A., and Hackstadt T. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol. Microbiol. 48 (2003) 671-683
73. Clifton D.R., Fields K.A., Grieshaber S.S., Dooley C.A., Fischer E.R., Mead D.J., Carabeo R.A., and Hackstadt T. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. USA 101 (2004) 10166-10171
74. Subtil A., Parsot C., and Dautry-Varsat A. Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol. Microbiol. 39 (2001) 792-800
75. Ho T.D., and Starnbach M.N. The Salmonella enterica serovar typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells. Infect. Immun. 73 (2005) 905-911
76. Matsumoto A. Structural characteristics of chlamydial bodies. In: Barron A.L. (Ed). Microbiology of Chlamydia (1988), CRC Press, Boca Raton, FL, USA 21-45
77. Henderson I.R., and Lam A.C. Polymorphic proteins of Chlamydia spp.-autotransporters beyond the Proteobacteria. Trends Microbiol. 9 (2001) 573-578
78. Longbottom D., Russell M., Dunbar S.M., Jones G.E., and Herring A.J. Molecular cloning and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope proteins from the Chlamydia psittaci subtype that causes abortion in sheep. Infect. Immun. 66 (1998) 1317-1324
79. Christiansen G., and Birkelund S. Chlamydia structure-A molecular approach to understand the structure of Chlamydia. In: Schacter J., Christiansen G., Clarke I.N., Hammerschlag M.R., Kaltenboeck B., Kuo C.C., Rank R.G., Ridgway G.L., Saikku P., Stamm W.E., Stephens R.S., Summersgill J.T., Timms P., and Wyrick P.B. (Eds). Chlamydial Infections-Proceedings of the Tenth International Symposium on Human Chlamydial Infections (2002), GRAFMAT Basim ve Reklam Sanayi Tic. Ltd. Sti., Basim Yeri 537-546
80. Wehrl W., Brinkmann V., Jungblut P.R., Meyer T.F., and Szczepek A.J. From the inside out-processing of the Chlamydial autotransporter PmpD and its role in bacterial adhesion and activation of human host cells. Mol. Microbiol. 51 (2004) 319-334